Summary
Pharmaceuticals in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Dutch pharmaceuticals market had total revenues of $5.3bn in 2020, representing a compound annual growth rate (CAGR) of 1.6% between 2016 and 2020.
- The Dutch lifestyle is generally considered to be one of the healthiest in Europe, which has is likely to reduce demand for pharmaceutical products as a healthy and active lifestyle minimizes the risk of illness and disease.
- In recent years, the Dutch government has undertaken a number of measures to make medicines in the country more affordable, such as reducing the average maximum allowable price for pharmaceutical products. This is likely to have an adverse impact on growth in the market.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in the Netherlands
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in the Netherlands
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Netherlands pharmaceuticals market with five year forecasts by both value and volume
Reasons to Buy
- What was the size of the Netherlands pharmaceuticals market by value in 2020?
- What will be the size of the Netherlands pharmaceuticals market in 2025?
- What factors are affecting the strength of competition in the Netherlands pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in the Netherlands's pharmaceuticals market?
'
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths of leading players?
7.4. What strategies do leading players follow?
7.5. Are there any threats towards leading players?
8 Company Profiles
8.1. Novartis AG
8.2. Pfizer Inc.
8.3. AstraZeneca PLC
8.4. GlaxoSmithKline Plc
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Netherlands pharmaceuticals market value: $ billion, 2016-20
Table 2: Netherlands pharmaceuticals market geography segmentation: $ billion, 2020
Table 3: Netherlands pharmaceuticals market value forecast: $ billion, 2020-25
Table 4: Netherlands pharmaceuticals market share: % share, by value, 2020
Table 5: Novartis AG: key facts
Table 6: Novartis AG: Annual Financial Ratios
Table 7: Novartis AG: Key Employees
Table 8: Novartis AG: Key Employees Continued
Table 9: Pfizer Inc.: key facts
Table 10: Pfizer Inc.: Annual Financial Ratios
Table 11: Pfizer Inc.: Key Employees
Table 12: Pfizer Inc.: Key Employees Continued
Table 13: AstraZeneca PLC: key facts
Table 14: AstraZeneca PLC: Annual Financial Ratios
Table 15: AstraZeneca PLC: Key Employees
Table 16: GlaxoSmithKline Plc: key facts
Table 17: GlaxoSmithKline Plc: Annual Financial Ratios
Table 18: GlaxoSmithKline Plc: Annual Financial Ratios (Continued)
Table 19: GlaxoSmithKline Plc: Key Employees
Table 20: GlaxoSmithKline Plc: Key Employees Continued
Table 21: Netherlands size of population (million), 2016-20
Table 22: Netherlands gdp (constant 2005 prices, $ billion), 2016-20
Table 23: Netherlands gdp (current prices, $ billion), 2016-20
Table 24: Netherlands inflation, 2016-20
Table 25: Netherlands consumer price index (absolute), 2016-20
Table 26: Netherlands exchange rate, 2016-20
List of Figures
Figure 1: Netherlands pharmaceuticals market value: $ billion, 2016-20
Figure 2: Netherlands pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 3: Netherlands pharmaceuticals market value forecast: $ billion, 2020-25
Figure 4: Forces driving competition in the pharmaceuticals market in the Netherlands, 2020
Figure 5: Drivers of buyer power in the pharmaceuticals market in the Netherlands, 2020
Figure 6: Drivers of supplier power in the pharmaceuticals market in the Netherlands, 2020
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the Netherlands, 2020
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in the Netherlands, 2020
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in the Netherlands, 2020
Figure 10: Netherlands pharmaceuticals market share: % share, by value, 2020
